Ozempic vs Trulicity

Quick Facts

  • Type: GLP-1
  • FDA Approval: Ozempic (2017), Trulicity (2014)
  • Frequency: Once weekly

Weight Loss Data

  • Ozempic: 12-14% in 68 weeks
  • Trulicity: 2-6% in 52 weeks

Primary Uses

  • Type 2 Diabetes
  • Weight Management
  • Cardiovascular Risk Reduction

Medication Overview

Ozempic

GLP-1

Basic Information

  • Generic Name: semaglutide
  • Manufacturer: Novo Nordisk
  • FDA Approval: 2017

Key Benefits

  • Significant A1C reduction
  • Weight loss support
  • Cardiovascular benefits
  • Once-weekly dosing

Trulicity

GLP-1

Basic Information

  • Generic Name: dulaglutide
  • Manufacturer: Eli Lilly
  • FDA Approval: 2014

Key Benefits

  • Once-weekly dosing
  • Ready-to-use pen
  • Cardiovascular benefits
  • No dose titration required for standard dose

Dosing Information

Dosing DetailsOzempicTrulicity
Starting Dose0.25mg0.75mg
Maintenance Dose0.5mg to 1mg1.5mg
Maximum Dose2mg4.5mg
ScheduleInject once weekly on the same day each weekInject once weekly at any time of day
TitrationStart with 0.25mg for 4 weeks, then 0.5mg for at least 4 weeks before increasing if neededStart with 0.75mg, can increase to 1.5mg after 4 weeks if needed

Side Effects

Ozempic

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal Pain
  • Constipation
  • Decreased Appetite

Trulicity

  • Nausea
  • Diarrhea
  • Vomiting
  • Abdominal Pain
  • Decreased Appetite
  • Indigestion

Practical Information

Ozempic

Storage & Handling

  • Storage: Refrigerate until first use, then can be stored at room temperature for up to 56 days
  • Needle Info: Comes with NovoFine® Plus needles

Insurance & Coverage

Widely covered for diabetes, may require prior authorization for weight management

Clinical Results

  • Weight Loss: 12-14%
  • Study Duration: 68 weeks
  • Study: STEP 1 clinical trial

Trulicity

Storage & Handling

  • Storage: Refrigerate until first use, then can be stored at room temperature for up to 14 days
  • Needle Info: Comes with attached hidden needle

Insurance & Coverage

Generally well-covered for diabetes treatment

Clinical Results

  • Weight Loss: 2-6%
  • Study Duration: 52 weeks
  • Study: AWARD clinical trial program

Medical Disclaimer: This comparison is for informational purposes only and should not replace professional medical advice. Always consult with your healthcare provider about which medication is right for you. Treatment decisions should be based on your individual medical needs and circumstances.

ShotWise App Interface

Track Your GLP-1 Journey with ShotWise

Get personalized dose tracking, side effect monitoring, and weight loss progress tracking all in one place. Join thousands of others managing their GLP-1 medications effectively.

Download ShotWise